Indian equity markets are expected to open in positive territory on Monday, with investor focus on third-quarter earnings and corporate developments. Market sentiment is being guided by earnings announcements, corporate actions, and global cues.
Gift Nifty indicated a higher start for domestic equities, signalling a positive opening in early trade. At around 8:15 am, Gift Nifty was trading near the 25,928 level, indicating a gain of 192 points, or 0.75 percent. Investors are primarily tracking Q3 results and company-specific updates.
Asian markets were trading higher. In Japan, the Nikkei 225 index touched a record high following the historic election victory of Prime Minister Sanae Takaichi. In early trade, the Nikkei 225 was up nearly 4 percent. South Korea’s Kospi was higher by 4.6 percent, while China’s CSI 300 index was trading 1.4 percent higher. These global cues are expected to influence domestic market sentiment.
Several major companies are scheduled to announce their third-quarter results on Monday. Companies reporting results include Zydus Lifesciences, Aurobindo Pharma, All Time Plastics, Amber Enterprises India, Bajaj Electricals, Bata India, Enviro Infra Engineers, PNGS Gargi Fashion Jewellery, GlaxoSmithKline Pharmaceuticals, Happiest Minds Technologies, Navin Fluorine International, PN Gadgil Jewellers, Ramco Cements, Sun Pharma Advanced Research Company, Trident, and Vadilal Industries.
Tata Steel reported its October–December quarter results, posting a year-on-year increase of 723 percent in net profit to ₹2,688.7 crore. The company’s revenue rose 6.3 percent year on year to ₹57,002.4 crore.
Sula Vineyards reported a decline in its December-quarter performance. The company’s net profit fell 67.6 percent year on year to ₹9.10 crore, while revenue declined 9.87 percent to ₹180.4 crore.
State Bank of India reported its highest-ever quarterly profit in the third quarter. The bank’s net profit rose 24.5 percent year on year to ₹21,028 crore, while net interest income increased 9 percent to ₹45,190 crore.
Kalyan Jewellers posted a significant year-on-year increase in its third-quarter performance. Net profit rose by over 90 percent to ₹416.30 crore, while revenue increased 42 percent to ₹10,343.42 crore.
Tata Chemicals announced plans to set up a greenfield manufacturing plant in Tamil Nadu with an investment of ₹515 crore. The project is aimed at expanding production capacity and strengthening the supply chain.
Hindustan Zinc announced the development of a zinc-ion battery prototype for renewable energy storage in collaboration with the Jawaharlal Nehru Centre for Advanced Scientific Research. The company stated that the technology is stable and reliable and can be used for large-scale energy storage.
Power Finance Corporation’s board approved the acquisition of a 52.63 percent stake in REC, paving the way for the merger of PFC and REC. Post-merger, the two entities will operate as a holding company and subsidiary.
IRB Infrastructure reported a 21.4 percent year-on-year increase in toll collection for January to ₹335.3 crore, compared with ₹276.1 crore in the same month last year.
Bharti Airtel has sought relief from the government regarding adjusted gross revenue dues. The company has requested the Department of Telecommunications to extend the same relief measures that were earlier granted to Vodafone Idea.
Mahindra Lifespace Developers commenced operations at an air-conditioner and compressor manufacturing plant with Mitsubishi Electric India at its industrial park in Chennai. The project is part of a joint venture with Japan’s Sumitomo Corporation.
Indian Renewable Energy Development Agency approved a plan to raise approximately ₹2,994 crore through a qualified institutional placement by issuing shares.
Aurobindo Pharma said the US Food and Drug Administration conducted an inspection at the Telangana unit of its subsidiary, Eugia Pharma Specialities.
BEML approved the establishment of a greenfield rail manufacturing plant in Umaria, Madhya Pradesh, with an investment of ₹1,500 crore. The new facility, named ‘BRAHMA’, is expected to expand the company’s rail segment manufacturing capacity.
